首页> 美国卫生研究院文献>EBioMedicine >Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkins lymphoma

【2h】

Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkins lymphoma

机译：侵袭性非霍奇金淋巴瘤患者的总生存率与炎性细胞因子的预后列线图

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BackgroundThis study aimed to investigate the association of pre-treatment inflammatory status with survival time and to develop a prognostic nomogram incorporating inflammatory cytokines in non-Hodgkin's lymphoma.

机译：背景这项研究旨在研究治疗前炎症状态与生存时间的关系，并开发结合非霍奇金淋巴瘤中炎性细胞因子的预后诺模图。

著录项

期刊名称 EBioMedicine
作者
Huijuan Zhong; Jia Chen; Shu Cheng; Suning Chen; Rong Shen; Qing Shi; Pengpeng Xu; Hengye Huang; Muchen Zhang; Li Wang; Depei Wu; Weili Zhao;
展开▼
作者单位

展开▼
年(卷),期 2019(41),-1
年度 2019
页码 167–174
总页数 8
原文格式 PDF
正文语种
中图分类
关键词
Non-Hodgkins lymphoma Lymphocyte-monocyte ratio Interleukin-2 receptor Tumor necrosis factor-α Prognosis;

机译：非霍奇金淋巴瘤;淋巴细胞-单核细胞比率;白介素-2受体;肿瘤坏死因子-α;预后;

相似文献

外文文献
中文文献
专利

1. Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma [J] . Huijuan Zhong, Jia Chen, Shu Cheng, EBioMedicine . 2019,第7期

机译：侵袭性非霍奇金淋巴瘤患者的总生存率与炎性细胞因子的预后列线图
2. Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas [J] . Annals of hematology . 2020,第6期

机译：血浆无细胞DNA是患有侵袭性非霍奇金淋巴瘤患者的预后生物标志物
3. Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): final analysis of survival in two consecutive ISC trials. [J] . Bouabdallah R, Stoppa AM, Coso D, Annals of oncology: official journal of the European Society for Medical Oncology . 2001,第4期

机译：侵袭性非霍奇金淋巴瘤和高危国际预后指数（IPI 3）患者进行一线强化序贯化疗（ISC）后的临床结果：两项连续的ISC试验的最终生存率分析。
4. Circulating Pro-inflammatory and Anti-inflammatory Cytokines in Patients with Unstable Angina Pectoris [C] . E.V. Shlyakhto, E.M. Nifontov, E.G. Sergeeva, International Congress on Coronary Artery Disease . 2007

机译：在不稳定的心绞痛患者中循环促炎和抗炎细胞因子
5. Prognostic Biomarkers for Diffuse Large B Cell Lymphoma Patient Survival after Treatment with Chemotherapy: A Retrospective Analysis of 88 Cases [D] . Bushra, Hamama tul. 2019

机译：弥漫性大B细胞淋巴瘤化疗后患者生存的预后生物标志物：88例回顾性分析
6. Are the High Serum Interleukin-6 and Vascular Endothelial Growth Factor Levels Useful Prognostic Markers in Aggressive Non-Hodgkin Lymphoma Patients? [O] . Hava Üsküdar Teke, Eren Gündüz, Olga Meltem Akay, 2015

机译：侵袭性非霍奇金淋巴瘤患者中高血清白介素6和血管内皮生长因子水平是否有用作为预后指标？
7. CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin’s and aggressive non-hodgkin’s lymphomas [O] . 2017

机译：基于CT的纹理分析可能为霍奇金淋巴瘤和侵袭性非霍奇金淋巴瘤患者提供与中期fdg-pet互补的预后信息

Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkins lymphoma

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅